Skip to content

Clinical trials

Terminated Carcinoma, Hepatocellular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Terminated Country / region: China Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20081
20102
20112
20143
20151
20162
20172
20181
20192
20204
20213
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University3
Zhejiang University2
Abbott1
Aeon Therapeutics (Shanghai) Co., Ltd.1
Antengene Therapeutics Limited1
Beijing Shenogen Biomedical Co., Ltd1
Bristol-Myers Squibb1
Cellxpert Biotechnology Corp.1
Fudan University1
Guangxi Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular28
Liver Neoplasms5
Neoplasms3
Adenocarcinoma1
Carcinoma1
Colorectal Neoplasms1
Digestive System Diseases1
Digestive System Neoplasms1
Liver Diseases1
Neoplasms by Histologic Type1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.